CooperVision Launches Multifocal Daily Disposable
CooperVision recently launched Proclear 1 Day Multifocal daily disposable contact lenses, which the company says provide presbyopic patients with excellent vision at all distances and address age-related dryness, all in the convenience of a daily disposable lens.
CooperVision says that its Proclear 1 Day Multifocal appeals to both daily and occasional wearers due to its healthier modality, ability to provide excellent vision at all distances, and the company's PC Technology. The Proclear 1 Day Multifocal can ease the adaptation that presbyopes encounter and can help prevent contact lens dropouts, according to the company.
CooperVision states that the center-near aspheric design and simplified fitting approach make it easier to select the right lens for patients in all stages of presbyopia— whether they are emerging or existing presbyopes. Proclear 1 Day Multifocal lenses are offered in a broad power range and are designed with a single power profile. With the use of a near boost in the non-dominant eye, CooperVision says that the lens can accommodate up to +2.50 add. As a result, practitioners will be able to more easily adjust prescriptions, contributing to less chair time, more profitable visits, and improved patient satisfaction, according to the company.
The lens will be launched initially in the United States, Canada, Australia, New Zealand, and in a number of European countries. More information on the lens including parameters will be available in the next Product Spectrum.
AMO to Have New President
Abbott Medical Optics (AMO) announced that it will have a new president when Jim Mazzo retires at the close of 2012. AMO's new president will be Murthy Simhambhatla, from Abbott Corporate, who will take over effective January 2013.
Mr. Mazzo has led the organization for the past 10 years through a spin-off, initial public offering, numerous acquisitions, sale and integration into Abbott, and, most recently, his term as chairman of AdvaMed.
Mr. Simhambhatla is an engineer by training, and has held a succession of management positions at Guidant and joined Abbott through the acquisition of that business. Before leading Ibis, Mr. Simhambhatla served as general manager of the vascular business in Australia and as divisional vice president and general manager of Abbott's drug-eluting stent business.
Mr. Mazzo will work with Mr. Simhambhatla over the next several months to aid him in a speedy transition to AMO and the visioncare market.
2012 ARVO Grants Awarded
The American Academy of Optometry (AAO) recently announced the winners of the 2012 Student Travel Fellowship Awards. The travel fellowships, supported by an educational grant from The Vision Care Institute, allowed 10 students to present their research at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in May 2012. The 2012 winners and their respective schools were:
• Faryan Tayyari, MS – University of Waterloo
• Daniel Coates, MS – University of California Berkeley
• Preethi Thiagarajan, BS Optometry, MS, FAAO – State University of New York College of Optometry
• Bradley Dougherty, OD, FAAO – The Ohio State University
• Thomas Keith, OD – UAB
• Gang Huang – Indiana University Bloomington
• Vinod Maseedupally, BS Optometry – University of New South Wales
• Naveen Yadav, MS – SUNY
• Vivian Wong, OD, FAAO – Indiana University
• Lin He, Bmed – University of Houston.
The AAO administers travel fellowships to encourage optometry students, optometric residents, and students in eye and vision-related graduate programs to attend key national meetings and exchange scientific ideas on research. Fellowships are awarded primarily for accomplishment and potential in optometric research and education.
Applications for student travel fellowships for the American Academy of Optometry's annual meeting, Academy 2012 Phoenix, will be available in June 2012. For more information visit www.aaopt.org/meetings/academy2012/student.
|New IAO Holds Vision By Design|
|Vision By Design 2012, the sixth annual education meeting of the Orthokeratology Academy of America, was held April 19 to 22 at the Scottsdale Resort & Conference Center. This year's conference included topics ranging from corneal reshaping/refractive therapy to myopia control and fitting large-diameter lenses for corneal rehabilitation. Seminars & Wet Labs were presented by a world class assembly of speakers with more than 40 hours of CE quality credit. The meeting also offered a Bootcamp for practitioners who were looking to improve their aptitude and knowledge with corneal reshaping and large-diameter lenses (sclerals). This three-and-a-half day event was a must attend for anyone interested in the field of corneal therapy and rehabilitation.|
Vision By Design 2012 was the first meeting of the new International Academy of Orthokeratology (IAO), and was attended by eyecare practitioners from more than 20 countries. During Saturday evening's gala dinner on April 21st, Bill Meyers, PhD, of Paragon Vision Sciences was awarded the Excellence in Orthokeratology Award in recognition of his vast contributions to the field of corneal reshaping. Jennifer Choo, OD, FAAO, was awarded a Research Fellowship for her studies of Microbial Keratitis and Corneal Epithelium in cat eyes.
Next year's event will return to the Chicago area and be held during the Spring quarter.
Holden Honored by University of Houston
Professor Brien Holden has received an Honorary Doctor of Humane Letters degree from the University of Houston. The degree was presented to Professor Holden, CEO of the Brien Holden Vision Institute, for his exceptional career in the field of optometry, his academic research, and his humanitarian accomplishments.
Commenting on the award, Professor Earl Smith III, Dean of the College of Optometry at the University said, “From our College's perspective, honorary doctorates are very special and are reserved for individuals who have made truly significant and lasting contributions to our profession.” The only other honorary doctorate was given to the late Dr. Irvin M. Borish.
“I am extremely honored to be awarded an Honorary Doctorate from the University of Houston and am humbled to be the second such awardee to the legendary Dr. Irvin M. Borish,” said Professor Holden.
Holden's research focus has been in the area of vision correction and ocular health, in particular with contact lenses, spectacles, and surgery. He has been a driving force behind the development of a number of lens products, including the third generation of soft contact lenses to correct astigmatism and as the co-developer of the breakthrough highly oxygen-permeable silicone hydrogel lenses.
His humanitarian efforts include the International Centre for Eyecare Education, where he serves as CEO, and Optometry Giving Sight, of which he is Executive Chair. Under Holden's direction, the Brien Holden Vision Institute was a founding partner and continues to be a major contributor to these organizations.
Holden's close ties with the University have nurtured collaborations between the university and the Brien Holden Vision Institute, which have led development in treatments for myopia and further investment in research facilities to tackle myopia worldwide.
|Keep up with industry news between issues of Contact Lens Spectrum by subscribing to our e-mail newsletter, Contact Lenses Today. Visit www.cltoday.com or the CLS site (www.clspectrum.com) to subscribe.|
|■ Quick-Med Technologies, Inc. has announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for the Company's pending patent, “System and Method for Enhancing the Efficacy of Antimicrobial Contact Lenses and Other Surfaces.” The forthcoming patent covers the method of post-treating Nimbus contact lens and other Nimbus surfaces to enhance antimicrobial efficacy and increase biofilm resistance. By introducing a citrate solution to a surface to which a Nimbus polymer has been non-leachably bound, the bactericidal performance is improved significantly. According to the company, this significantly enhanced performance is sustained even after rinsing the lenses.|
■ American optometrists are being invited to register for the World Council of Optometry's next conference and join professionals from around the world who are gathering in Chicago to discuss ways to improve eye and vision care globally. This conference—Advancing Optometry Worldwide—will be a chance for North American optometrists to share their experiences with professionals from more than 20 countries. The program includes lectures on diabetes; the eye in neurological disease; and vision and aging. Advancing Optometry Worldwide is taking place at the Renaissance Blackstone Hotel, Chicago, from June 24 to 26 and is timed to coincide with the American Optometric Association's Optometry's Meeting, also in Chicago. Visit www.worldoptometry.org/chicago.
■ TearScience, Inc. announced the promotion of Nicole Wicker to Chief Financial Officer (CFO). Nicole has served as TearScience's Vice President of Finance since joining the company in December 2008.
■ The National Optometry Hall of Fame, administered by Optometry Cares – The AOA Foundation, will welcome five new inductees during Optometry's Meeting in Chicago, Ill. This year's inductees include Kevin L. Alexander, OD, PhD, from Fullerton, Calif.; James A. Boucher, OD, from Laramie, Wyo.; William E. Cochran, OD, DOS, from Cordova, Tenn.; Frank Fontana, OD, from St. Louis, Mo.; and Thomas L. Lewis, OD, PhD, from Dresher, Penn.
■ Optometry Giving Sight has named Dr. Mario Gutierrez from San Antonio, Texas as its Vision Source Philanthropist of the Year; the organization has also named Cole, Krohn and Jensen from Fresno, Calif. as its Vision Source Practice of the Year. The awards recognize an individual and practice that demonstrate a tremendous passion for the elimination of refractive error blindness and low vision through their own personal giving; practice fundraising and advocacy among their peers.
■ The Boston Foundation for Sight recently announced that the University of California, San Francisco, Department of Ophthalmology and Francis I. Proctor Foundation has established a new clinic to treat complex corneal disease that will offer the Boston Foundation for Sight's scleral lens called prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.